Immunome, Inc.IMNMNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank86
5Y CAGR+44.5%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

5Y CAGR
+44.5%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
6.3x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202551.40%
20247.06%
2023-74.11%
2022-44.39%
2021-26.63%
20208.15%
201974.37%
20180.00%